DK400685A - Praeparat med kontrolleret afgivelse - Google Patents

Praeparat med kontrolleret afgivelse Download PDF

Info

Publication number
DK400685A
DK400685A DK400685A DK400685A DK400685A DK 400685 A DK400685 A DK 400685A DK 400685 A DK400685 A DK 400685A DK 400685 A DK400685 A DK 400685A DK 400685 A DK400685 A DK 400685A
Authority
DK
Denmark
Prior art keywords
drug
tablet
active substance
preparation
delivery preparation
Prior art date
Application number
DK400685A
Other languages
English (en)
Other versions
DK164256C (da
DK164256B (da
DK400685D0 (da
Inventor
Bo Magnus Ekman
Aake Rikard Lindahl
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Publication of DK400685D0 publication Critical patent/DK400685D0/da
Publication of DK400685A publication Critical patent/DK400685A/da
Publication of DK164256B publication Critical patent/DK164256B/da
Application granted granted Critical
Publication of DK164256C publication Critical patent/DK164256C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Temperature (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK400685A 1984-09-06 1985-09-02 Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf DK164256C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8404467 1984-09-06
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations

Publications (4)

Publication Number Publication Date
DK400685D0 DK400685D0 (da) 1985-09-02
DK400685A true DK400685A (da) 1986-03-07
DK164256B DK164256B (da) 1992-06-01
DK164256C DK164256C (da) 1992-10-19

Family

ID=20356934

Family Applications (1)

Application Number Title Priority Date Filing Date
DK400685A DK164256C (da) 1984-09-06 1985-09-02 Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf

Country Status (21)

Country Link
US (1) US4824678A (da)
EP (1) EP0173928B1 (da)
JP (1) JP2527713B2 (da)
KR (1) KR930003114B1 (da)
AT (1) ATE53490T1 (da)
AU (1) AU576891B2 (da)
CA (1) CA1252723A (da)
DE (1) DE3578123D1 (da)
DK (1) DK164256C (da)
ES (1) ES8702138A1 (da)
FI (1) FI87042C (da)
GR (1) GR852158B (da)
HU (1) HU194495B (da)
IE (1) IE58263B1 (da)
IL (2) IL76256A (da)
NO (1) NO169996C (da)
NZ (1) NZ213245A (da)
PH (1) PH22119A (da)
PT (1) PT81092B (da)
SE (1) SE8404467D0 (da)
ZA (1) ZA856547B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
DE3586600T2 (de) * 1984-02-10 1993-02-18 Benzon Pharma As Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
JPH0794379B2 (ja) * 1990-08-07 1995-10-11 ファイザー・インコーポレーテッド 放出製剤における界面重合膜の使用方法
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
GB2267219B (en) * 1992-05-28 1996-04-03 Elan Corp Plc Differential release tablet with multiple active agents
AU6358594A (en) * 1993-03-09 1994-09-26 Middlesex Sciences, Inc. Macromolecular microparticles and methods of production
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
EP1411901B1 (en) * 2001-07-04 2010-08-18 Sun Pharma Advanced Research Company Ltd Gastric retention controlled drug delivery system
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
ATE287259T1 (de) 2001-12-19 2005-02-15 Astrazeneca Ab Neue filmbeschichtung enthaltend ein äthylacrylate/methylmethacrylate-copolymer und polyvinylacetat
ES2399880T3 (es) * 2002-03-15 2013-04-04 Cypress Bioscience, Inc. Milnaciprán para el tratamiento del síndrome del intestino irritable
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
CA2629740A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) * 2011-12-19 2012-05-09 岳阳新华达制药有限公司 含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
WO2017026950A1 (en) 2015-08-07 2017-02-16 Santa Farma Ilac San. A. S. Controlled release propiverine formulations
EP3796908B1 (en) 2018-11-16 2023-05-10 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
WO2022115056A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Sustained release formulation compositions comprising propiverine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108838C (da) * 1956-03-27
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
EP0013131A3 (en) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmaceutical composition in solid dosage form, and process for its production
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Also Published As

Publication number Publication date
KR930003114B1 (ko) 1993-04-19
AU4693585A (en) 1986-03-13
EP0173928A1 (en) 1986-03-12
PT81092A (en) 1985-10-01
GR852158B (da) 1986-01-08
NO169996C (no) 1992-09-02
JP2527713B2 (ja) 1996-08-28
NZ213245A (en) 1988-06-30
DK164256C (da) 1992-10-19
SE8404467D0 (sv) 1984-09-06
NO853407L (no) 1986-03-07
FI87042C (fi) 1992-11-25
KR860002271A (ko) 1986-04-24
CA1252723A (en) 1989-04-18
DK164256B (da) 1992-06-01
FI853406L (fi) 1986-03-07
NO169996B (no) 1992-05-25
ES546728A0 (es) 1986-12-16
FI87042B (fi) 1992-08-14
IL76256A (en) 1990-06-10
IE852070L (en) 1986-03-06
DK400685D0 (da) 1985-09-02
HUT40333A (en) 1986-12-28
IE58263B1 (en) 1993-08-25
PT81092B (pt) 1988-01-22
ES8702138A1 (es) 1986-12-16
ZA856547B (en) 1986-04-30
AU576891B2 (en) 1988-09-08
HU194495B (en) 1988-02-29
IL76257A (en) 1989-05-15
IL76256A0 (en) 1986-01-31
JPS61112013A (ja) 1986-05-30
PH22119A (en) 1988-06-01
FI853406A0 (fi) 1985-09-05
US4824678A (en) 1989-04-25
DE3578123D1 (de) 1990-07-19
EP0173928B1 (en) 1990-06-13
ATE53490T1 (de) 1990-06-15

Similar Documents

Publication Publication Date Title
DK400685D0 (da) Praeparat med kontrolleret afgivelse
HUT59321A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
ATE150963T1 (de) Kugelförmige granula mit kern sowie deren herstellung
KR910011242A (ko) 서방성 약학제제 및 그의 제조방법
IE883810L (en) Sustained release pharmaceutical compositions
DE3767600D1 (de) Ibuprofen-formulation mit verzoegerter wirkstoffabgabe.
ATE229327T1 (de) Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen
CA2281420A1 (en) Preparation of pharmaceutically-active granules
DE3680450D1 (de) Pharmazeutische zubereitungen von metoprolol mit kontrollierter wirkstoffabgabe, verfahren zu ihrer herstellung und verwendung dieser zubereitungen.
KR880001289A (ko) 서방성 제제 및 그의 제조방법
NO175186C (no) Fremgangsmåte for fremstilling av et osmotisk avgivende, oralt avleveringssystem inneholdende et moderat vannopplöselig, farmasöytisk akseptabelt salt av metoprolol
EP0171528A3 (en) Controlled release pharmaceutical preparations
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
NO170424C (no) Harpikspartikler av desintegrasjonstypen, deres fremstilling og beleggsmiddel inneholdende slike partikler
CA2417887A1 (en) Particulate composition of eletriptan
JPS5549312A (en) Preparation of slow-releasing medicine

Legal Events

Date Code Title Description
PBP Patent lapsed